Academia Sinica announces licencing of Covid-19 tests
By ECCT staff writers
Taiwan’s Academia Sinica has announced licensing opportunities for rapid screening of the Covid-19 virus antigen.
Academia Sinica has successfully developed a prototype for rapid screening of Covid-19 virus antigen using an immunological assay. Today, Academia Sinica announced licensing opportunities for domestic and international companies to commercialize this technology in international markets. Interested parties are encouraged to contact the Department of Intellectual Property and Technology Transfer, Academia Sinica, for more information.
On 23 March, 2020 Academia Sinica and the Ministry of Economic Affairs, jointly briefed local manufacturers on the licensing procedures of the Covid-19 immunological detection technology for the Taiwanese market. On 10 April, materials and protocols were transferred to seven Taiwanese manufacturers for further development for approval and commercialization in Taiwan. Today’s announcement extends the scope of commercialization to international markets.